MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/heartjnl-2022-321874

Медицинская библиотека · Heart (British Cardiac Society) · 2023

Outcomes in patients with moderate and asymptomatic severe aortic stenosis followed up in heart valve clinics.

Paolisso Pasquale, Beles Monika, Belmonte Marta, Gallinoro Emanuele, De Colle Cristina, Mileva Niya, Bertolone Dario Tino, Deschepper Celine, Spapen Jerrold, Brouwers Sofie, Degrieck Ivan, Casselman Filip, Stockman Bernard, Van Praet Frank, Penicka Martin, Collet Carlos, Wyffels Eric, Vanderheyden Marc, Barbato Emanuele, Bartunek Jozef, Van Camp Guy

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Heart valve clinics (HVC) have been introduced to manage patients with valvular heart disease within a multidisciplinary team.

OBJECTIVE

To determine the outcome benefit of HVC approach compared with standard of care (SOC) for patients with moderate and asymptomatic severe aortic stenosis (mAS and asAS).

METHODS

Single-centre, observational registry of patients with mAS and asAS with at least one cardiac ambulatory consultation at our Cardiovascular Centre. Based on the outpatient strategy, patients were divided into HVC group, if receiving at least one visit at HVC, and SOC group, if followed by routine cardiac consultations.

RESULTS

2129 patients with mAS and asAS were divided into those followed in HVC (n=251) versus SOC group (n=1878). The mean age was 76.5±12.4 years; 919 (43.2%) had asAS. During a follow-up of 4.8±1.8 years, 822 patients (38.6%) died, 307 (14.4%) were hospitalised for heart failure and 596 (28%) underwent aortic valve replacement (AVR). After propensity score matching, the number of consultations per year, exercise stress tests, brain natriuretic peptide (BNP) determinations and CTs were higher in the HVC cohort (p<0.05 for all). A shorter time between indication of AVR and less advanced New York Heart Association class was reported in the HVC cohort (p<0.001 and p=0.032). Compared with SOC, the HVC approach was associated with reduced all-cause mortality (HR=0.63, 95% CI 0.40 to 0.98, p=0.038) and cardiovascular death (p=0.030). At multivariable analysis, the HVC remained an independent predictor of all-cause mortality (HR=0.54, 95% CI 0.34 to 0.85, p=0.007).

CONCLUSIONS

In patients with mAS and asAS, the HVC approach was associated with more efficient management and outcome benefit compared with SOC.

Для цитирования: Paolisso Pasquale, Beles Monika, Belmonte Marta, Gallinoro Emanuele, De Colle Cristina, Mileva Niya, Bertolone Dario Tino, Deschepper Celine, Spapen Jerrold, Brouwers Sofie, Degrieck Ivan, Casselman Filip, Stockman Bernard, Van Praet Frank, Penicka Martin, Collet Carlos, Wyffels Eric, Vanderheyden Marc, Barbato Emanuele, Bartunek Jozef, Van Camp Guy. Outcomes in patients with moderate and asymptomatic severe aortic stenosis followed up in heart valve clinics.. Heart (British Cardiac Society). 2023. DOI: 10.1136/heartjnl-2022-321874.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.